Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Dominjon, F."'
Autor:
Komajda, M. Michel, Isnard, R., Cohen-Solal, A., Metra, M., Pieske, B., Piotr Ponikowski, Voors, A. A., Dominjon, F., Henon-Goburdhun, C., Pannaux, M., Bohm, M.
Publikováno v:
European Journal of Heart Failure, 19(11), 1495-1503. Wiley
ResearcherID
Web of Science
ResearcherID
Web of Science
Aims This randomized, double-blind, placebo-controlled trial assessed whether heart rate (HR) reduction with ivabradine improves cardiac function in heart failure with preserved ejection fraction (HFpEF). Methods and results The prEserveD left ventri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c6ace8d6b80b934c5aeea3d57a20ac4f
https://research.rug.nl/en/publications/5063fb0a-1116-404d-ab1f-184a6242cfc2
https://research.rug.nl/en/publications/5063fb0a-1116-404d-ab1f-184a6242cfc2
Autor:
Anker, S.D., Schroeder, S., Atar, D., Bax, J.J., Ceconi, C., Cowie, M.R., Crisp, A., Dominjon, F., Ford, I., Ghofrani, H.A., Gropper, S., Hindricks, G., Hlatky, M.A., Holcomb, R., Honarpour, N., Jukema, J.W., Kim, A.M., Kunz, M., Lefkowitz, M., Floch, C.L., Landmesser, U., McDonagh, T.A., McMurray, J.J., Merkely, B., Packer, M., Prasad, K., Revkin, J., Rosano, G.M.C., Somaratne, R., Stough, W.G., Voors, A.A., Ruschitzka, F.
Publikováno v:
European Journal of Heart Failure, 18(6), 727-727
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::988bcb3fc99932637c35bef7ec4a25e1
https://hdl.handle.net/1887/114146
https://hdl.handle.net/1887/114146
Publikováno v:
HOTLAB
HOTLAB, Sep 2015, Leuven, Belgium
HOTLAB, Sep 2015, Leuven, Belgium
International audience; PHENIX is a French fast breeder nuclear power plant stopped in 2009. The critical path of the plant dismantling is the evacuation of the fuel elements and after the evacuation of the Lateral Neutron Shielding Assemblies (LNSA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dd4725736ed53094561e3f32f14e3283
https://hal-cea.archives-ouvertes.fr/cea-02489543
https://hal-cea.archives-ouvertes.fr/cea-02489543
Publikováno v:
ANS 2015 Annual Meeting Nuclear Technology An Essential Part of the solution
ANS 2015 Annual Meeting Nuclear Technology An Essential Part of the solution, Jun 2015, San Antonio Tx, United States
ANS 2015 Annual Meeting Nuclear Technology An Essential Part of the solution, Jun 2015, San Antonio Tx, United States
International audience; Phenix is a French fast breeder nuclear power plant which went critical in 1973 and ceased power operation in 2009.The decommissioning project started in 2005, in order to start immediately after the final shutdomn and archiev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b492ca358ba70073b2b2180baafd6cc3
https://hal-cea.archives-ouvertes.fr/cea-02509092
https://hal-cea.archives-ouvertes.fr/cea-02509092
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Komajda M; Department of Cardiology, University of Pierre and Marie Curie Paris VI, La Pitié-Salpêtrière Hospital, Paris, France., Isnard R; Department of Cardiology, University of Pierre and Marie Curie Paris VI, La Pitié-Salpêtrière Hospital, Paris, France., Cohen-Solal A; UMR-S 942, Department of Cardiology, Paris Diderot University, Sorbonne Paris Centre, Lariboisière Hospital, Paris, France., Metra M; Department of Cardiology, University of Brescia, Brescia, Italy., Pieske B; Department of Cardiology, Charité University, Berlin, Germany., Ponikowski P; Department of Heart Diseases, Medical University and Centre for Heart Diseases, Military Hospital, Wrocław, Poland., Voors AA; Department of Cardiology, University of Groningen, Groningen, the Netherlands., Dominjon F; Department of Cardiovascular Development, Institut de Recherches Internationales Servier (IRIS), Suresnes, France., Henon-Goburdhun C; Department of Cardiovascular Development, Institut de Recherches Internationales Servier (IRIS), Suresnes, France., Pannaux M; Department of Methodology and Data Valorisation, Institut de Recherches Internationales Servier (IRIS), Suresnes, France., Böhm M; Department of Cardiology, Universitätskliniken des Saarlandes, Klinikum für Innere Medizin III, Homburg/Saar, Germany.
Publikováno v:
European journal of heart failure [Eur J Heart Fail] 2017 Nov; Vol. 19 (11), pp. 1495-1503. Date of Electronic Publication: 2017 Apr 30.
Autor:
Anker SD; Innovative Clinical Trials, Department of Cardiology & Pneumology, University Medical Center Göttingen (UMG), Germany., Schroeder S; Bayer Pharma AG, Berlin, Germany., Atar D; Department of Cardiology B, Oslo University Hospital Ulleval and University of Oslo, Norway., Bax JJ; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands., Ceconi C; Unit of Cardiology, Hospital of Desenzano del Garda, Desenzano del Garda, Italy., Cowie MR; National Heart and Lung Institute, Imperial College London, London, UK., Crisp A; GlaxoSmithKline, Middlesex, UK., Dominjon F; Servier International, Paris, France., Ford I; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK., Ghofrani HA; University of Giessen and Marburg Lung Center, UGMLC [member of the German Center for Lung Research (DZL)], Giessen, Germany.; Kerckhoff-Klinik Bad Nauheim, Germany.; Imperial College London, UK., Gropper S; Boehringer-Ingelheim GmBH & Co. KG, Ingelheim, Germany., Hindricks G; Department of Electrophysiology, Heart Center, University of Leipzig, Leipzig, Germany., Hlatky MA; Stanford University School of Medicine, Stanford, CA, USA., Holcomb R; Independent Biostatistician, Minneapolis, MN, USA., Honarpour N; Amgen, Inc., Thousand Oaks, CA, USA., Jukema JW; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands., Kim AM; Pfizer, Inc., Cambridge, MA, USA., Kunz M; Bayer Pharma AG, Berlin, Germany., Lefkowitz M; Novartis Pharmaceuticals, East Hanover, NJ, USA., Floch CL; Servier International, Paris, France., Landmesser U; Department of Cardiology, Charité Universitätsmedizin Berlin, Berlin, Germany., McDonagh TA; King's College Hospital, London, UK., McMurray JJ; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Merkely B; Semmelweis University Heart and Vascular Center, Budapest, Hungary., Packer M; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA., Prasad K; United Kingdom Medicines and Healthcare Products Regulatory Agency, London, UK., Revkin J; Pfizer, Inc., Cambridge, MA, USA., Rosano GM; IRCCS San Raffaele Hospital Roma, Rome, Italy.; Cardiovascular and Cell Sciences Institute, St. George's University of London, London, UK., Somaratne R; Amgen, Inc., Thousand Oaks, CA, USA., Stough WG; Campbell University College of Pharmacy and Health Sciences, NC, USA., Voors AA; University of Groningen, Groningen, The Netherlands., Ruschitzka F; Department of Cardiology, Heart Failure Clinic and Transplantation, University Heart Center Zurich, Zurich, Switzerland.
Publikováno v:
European journal of heart failure [Eur J Heart Fail] 2016 Jun; Vol. 18 (6), pp. 727.